CYTOKINETICS INC (CYTK)       40.49  -0.37 (-0.91%)

40.49  -0.37 (-0.91%)

US23282W6057 - Common Stock - After market: 40.49 0 (0%)

Buy % Consensus

83
Analysts have set a mean price target of 69.75. This target is 72.27% above the current price.
CYTK was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CYTK.
In the previous month the buy percentage consensus was at a similar level.
CYTK was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 40.4955.5570.3869.7586.10 - 37.19% 73.82% 72.27% 112.65%

Up and Down Grades

Date Firm Action Rating
2022-10-11 UBS Initiate Buy
2022-10-03 JMP Securities Maintains Market Outperform
2022-08-05 Raymond James Maintains Outperform
2022-07-15 Morgan Stanley Maintains Overweight
2022-06-10 Piper Sandler Maintains Overweight
2022-05-24 Goldman Sachs Maintains Buy
2022-05-16 Mizuho Maintains Buy
2022-05-05 Needham Maintains Buy
2022-04-29 HC Wainwright & Co. Maintains Buy
2021-12-22 Oppenheimer Initiate Outperform
2021-12-21 HC Wainwright & Co. Maintains Buy
2021-12-10 JP Morgan Initiate Overweight
2021-12-01 Mizuho Maintains Buy
2021-11-04 HC Wainwright & Co. Maintains Buy
2021-10-08 Morgan Stanley Maintains Overweight
2021-10-07 Jefferies Initiate Buy
2021-08-06 HC Wainwright & Co. Maintains Buy
2021-07-20 Barclays Maintains Overweight
2021-07-19 Needham Maintains Buy
2021-07-19 HC Wainwright & Co. Maintains Buy
2021-04-19 Morgan Stanley Maintains Overweight
2021-03-12 Wolfe Research Initiate Outperform

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA